{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:07:35Z","timestamp":1789556855651,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011643","name":"Blavatnik Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011643","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1053\/j.seminoncol.2022.07.005","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T07:59:38Z","timestamp":1659686378000},"page":"363-370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans"],"prefix":"10.1053","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8860-1382","authenticated-orcid":false,"given":"Harshraj","family":"Leuva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Brau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon T.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhjot","family":"Mundi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta-Chueh Melody","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Luhrs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeun-Hee Anna","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tito","family":"Fojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2022.07.005_bib0001","unstructured":"WHO. Weekly epidemiological update on COVID-19 - 27 April 2022. Available from: https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update-on-covid-19\u201427-april-2022."},{"issue":"2","key":"10.1053\/j.seminoncol.2022.07.005_bib0002","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/all.14657","article-title":"Risk factors for severe and critically ill COVID-19 patients: a review","volume":"76","author":"Gao","year":"2021","journal-title":"Allergy"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.07.005_bib0003","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jamainternmed.2020.8360","article-title":"Association of smoking and cumulative pack-year exposure with COVID-19 outcomes in the Cleveland Clinic COVID-19 Registry","volume":"181","author":"Lowe","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"19","key":"10.1053\/j.seminoncol.2022.07.005_bib0004","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months","volume":"385","author":"Thomas","year":"2021","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1053\/j.seminoncol.2022.07.005_bib0005","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1056\/NEJMoa2113017","article-title":"Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase","volume":"385","author":"El Sahly","year":"2021","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1053\/j.seminoncol.2022.07.005_bib0006","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1053\/j.seminoncol.2022.07.005_bib0007","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1056\/NEJMoa2114228","article-title":"Waning immunity after the BNT162b2 vaccine in Israel","volume":"385","author":"Goldberg","year":"2021","journal-title":"N Engl J Med"},{"issue":"49","key":"10.1053\/j.seminoncol.2022.07.005_bib0008","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.15585\/mmwr.mm7049a2","article-title":"Comparative effectiveness and antibody responses to Moderna and Pfizer-BioNTech COVID-19 vaccines among hospitalized veterans - five veterans affairs medical centers, United States, February 1-September 30, 2021","volume":"70","author":"Bajema","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10328","key":"10.1053\/j.seminoncol.2022.07.005_bib0009","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","article-title":"Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression","volume":"399","author":"Feikin","year":"2022","journal-title":"Lancet"},{"issue":"7","key":"10.1053\/j.seminoncol.2022.07.005_bib0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.15585\/mmwr.mm7107e2","volume":"71","author":"Ferdinands","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1053\/j.seminoncol.2022.07.005_bib0011","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2201570","article-title":"Protection by a Fourth Dose of BNT162b2 against Omicron in Israel","author":"Bar-On","year":"2022","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.seminoncol.2022.07.005_bib0012","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jnci\/djaa168","article-title":"Clinical characteristics and outcomes of COVID-19-infected cancer patients: a systematic review and meta-analysis","volume":"113","author":"Zhang","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.07.005_bib0013","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1053\/j.seminoncol.2022.07.005_bib0014","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/cncr.33386","article-title":"Mortality in hospitalized patients with cancer and coronavirus disease 2019: a systematic review and meta-analysis of cohort studies","volume":"127","author":"Desai","year":"2021","journal-title":"Cancer"},{"issue":"10241","key":"10.1053\/j.seminoncol.2022.07.005_bib0015","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(20)31187-9","article-title":"Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study","volume":"395","author":"Kuderer","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1053\/j.seminoncol.2022.07.005_bib0016","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1200\/GO.20.00444","article-title":"Determinants of COVID-19 mortality in patients with cancer from a community oncology practice in Brazil","volume":"7","author":"Ferrari","year":"2021","journal-title":"JCO Glob Oncol"},{"issue":"20","key":"10.1053\/j.seminoncol.2022.07.005_bib0017","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1200\/JCO.21.01074","article-title":"Outcomes of COVID-19 in patients with cancer: Report From the National COVID Cohort Collaborative (N3C)","volume":"39","author":"Sharafeldin","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2022.07.005_bib0018","article-title":"Breakthrough SARS-CoV-2 infections, hospitalizations, and mortality in vaccinated patients with cancer in the US between December 2020 and November 2021","author":"Wang","year":"2022","journal-title":"JAMA Oncol"},{"issue":"11","key":"10.1053\/j.seminoncol.2022.07.005_bib0019","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1002\/ijc.33148","article-title":"Low prevalence of IgG antibodies to SARS-CoV-2 in cancer patients with COVID-19","volume":"147","author":"Liu","year":"2020","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1053\/j.seminoncol.2022.07.005_bib0020","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1470-2045(21)00213-8","article-title":"Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study","volume":"22","author":"Monin","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminoncol.2022.07.005_bib0021","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejca.2021.10.014","article-title":"Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis","volume":"160","author":"Becerril-Gaitan","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2022.07.005_bib0022","unstructured":"US Department of Veterans Affairs: COVID-19 vaccination plan for the Veterans Health Administration Version 2.0. https:\/\/www.publichealth.va.gov\/docs\/n-coronavirus\/VHA-COVID-Vaccine-Plan-14Dec2020.pdf."},{"issue":"6","key":"10.1053\/j.seminoncol.2022.07.005_bib0023","doi-asserted-by":"crossref","first-page":"206","DOI":"10.15585\/mmwr.mm7106a4","article-title":"Genomic surveillance for SARS-CoV-2 variants: predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022","volume":"71","author":"Lambrou","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"10.1053\/j.seminoncol.2022.07.005_bib0024","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.18632\/aging.103344","article-title":"Why does COVID-19 disproportionately affect older people?","volume":"12","author":"Mueller","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"10","key":"10.1053\/j.seminoncol.2022.07.005_bib0025","doi-asserted-by":"crossref","first-page":"e13230","DOI":"10.1111\/acel.13230","article-title":"COVID-19 is an emergent disease of aging","volume":"19","author":"Santesmasses","year":"2020","journal-title":"Aging Cell"},{"key":"10.1053\/j.seminoncol.2022.07.005_bib0026","article-title":"Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis","volume":"375","author":"Talic","year":"2021","journal-title":"Bmj"},{"issue":"13","key":"10.1053\/j.seminoncol.2022.07.005_bib0027","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1200\/JCO.21.02419","article-title":"Risk and outcome of breakthrough COVID-19 infections in vaccinated patients with cancer: real-world evidence from the National COVID Cohort Collaborative","volume":"40","author":"Song","year":"2022","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1053\/j.seminoncol.2022.07.005_bib0028","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ccell.2021.07.012","article-title":"Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies","volume":"39","author":"Greenberger","year":"2021","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1053\/j.seminoncol.2022.07.005_bib0029","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ccell.2021.06.014","article-title":"Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma","volume":"39","author":"Van Oekelen","year":"2021","journal-title":"Cancer Cell"},{"issue":"23","key":"10.1053\/j.seminoncol.2022.07.005_bib0030","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1182\/blood.2021011568","article-title":"Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia","volume":"137","author":"Herishanu","year":"2021","journal-title":"Blood"},{"issue":"16","key":"10.1053\/j.seminoncol.2022.07.005_bib0031","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1182\/bloodadvances.2021005094","article-title":"Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma","volume":"5","author":"Perry","year":"2021","journal-title":"Blood Adv"},{"issue":"8","key":"10.1053\/j.seminoncol.2022.07.005_bib0032","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1016\/S2352-3026(21)00169-1","article-title":"Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study","volume":"8","author":"Maneikis","year":"2021","journal-title":"Lancet Haematol"},{"issue":"7","key":"10.1053\/j.seminoncol.2022.07.005_bib0033","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S1470-2045(20)30314-4","article-title":"COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study","volume":"21","author":"Garassino","year":"2020","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.07.005_bib0034","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jamaoncol.2021.5771","article-title":"Association of COVID-19 vaccination with SARS-CoV-2 infection in patients with cancer: a US Nationwide Veterans Affairs Study","volume":"8","author":"Wu","year":"2022","journal-title":"JAMA Oncol"},{"issue":"8","key":"10.1053\/j.seminoncol.2022.07.005_bib0035","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaoncol.2021.2155","article-title":"Evaluation of seropositivity following BNT162b2 messenger RNA vaccination for SARS-CoV-2 in patients undergoing treatment for cancer","volume":"7","author":"Massarweh","year":"2021","journal-title":"JAMA Oncol"},{"issue":"9","key":"10.1053\/j.seminoncol.2022.07.005_bib0036","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1182\/blood.2021012443","article-title":"Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell-directed therapies","volume":"138","author":"Ghione","year":"2021","journal-title":"Blood"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775422000598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775422000598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:57:15Z","timestamp":1758805035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775422000598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0093775422000598"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2022.07.005","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminoncol.2022.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}